Cirrhosis is widely prevalent worldwide and can be a consequence of different causes, such
as obesity, non-alcoholic fatty liver disease, high alcohol consumption, hepatitis B or C …

Patients with cirrhosis frequently acquire complex changes in their haemostatic system
including a decreased platelet count and decreased levels of various haemostatic proteins …

Background & Aims Studies on platelet aggregation in cirrhosis are controversial because
interpretation of platelet function is challenged by thrombocytopenia. We conducted a …

The expression splanchnic vein thrombosis encompasses Budd-Chiari syndrome and portal
vein thrombosis. These disorders have common characteristics: they are both rare diseases …

Liver cirrhosis (LC) is associated with portal venous thrombosis (PVT) in roughly 20% of
cirrhotic patients but the underlying mechanism is still unclear. Low-grade endotoxemia by …

In selected patients with cirrhosis and ascites, transjugular intrahepatic portosystemic shunt
(TIPS) placement improves control of ascites and may reduce mortality. In this review, we …

Hospital‐associated venous thromboembolism (HA‐VTE) is a major cause of morbidity and
mortality and is internationally recognized as a significant patient safety issue. While …

Introduction Immunothrombosis has recently been used to describe the responses/
mechanisms in thrombosis. Systemic inflammatory markers are prognostic markers for a …

The Billroth IV consensus was developed during a consensus meeting of the Austrian
Society of Gastroenterology and Hepatology (ÖGGH) and the Austrian Society of …

Venous thrombosis is a frequent complication in cancer and is associated with high
morbidity and mortality. Hepatocellular carcinoma (HCC) is the most common primary liver …